King's College London

Research portal

Neuropharmacology, 0028-3908

Journal

  1. The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets

    Fisher, R., Hikima, A., Morris, R., Jackson, M. J., Rose, S., Varney, M. A., Depoortere, R. & Newman-Tancredi, A., 1 May 2020, In: Neuropharmacology. 167, 107997.

    Research output: Contribution to journalArticlepeer-review

  2. The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and antiparkinsonian-like effects in MPTP-treated marmosets

    Fisher, R., Hikima, A., Morris, R., Jackson, M. J., Salvage, S., Varney, M. A., Depoortere, R. & Newman-Tancredi, A., 10 Feb 2020, In: Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2020.107997.

    Research output: Contribution to journalArticlepeer-review

  3. Cyto-nuclear shuttling of afadin is required for rapid estradiol-mediated modifications of histone H3

    Sellers, K. J., Watson, I. A., Gresz, R., Raval, P. & Srivastava, D. P., Dec 2018, In: Neuropharmacology. 143, p. 153-162

    Research output: Contribution to journalArticlepeer-review

  4. LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm

    Timmermann, C., Spriggs, M. J., Kaelen, M., Leech, R., Nutt, D. J., Moran, R. J., Carhart-Harris, R. L. & Muthukumaraswamy, S. D., Nov 2018, In: Neuropharmacology. 142, p. 251-262 12 p.

    Research output: Contribution to journalArticlepeer-review

  5. Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner

    Duty, S., Boshoff, E. L. & Fletcher, E. J., 15 Jul 2018, In: Neuropharmacology. 137, 0, p. 156-163

    Research output: Contribution to journalArticlepeer-review

  6. Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol

    Fernández-Calle, R., Vicente-Rodríguez, M., Pastor, M., Gramage, E., Di Geronimo, B., Zapico, J. M., Coderch, C., Pérez-García, C., Lasek, A. W., de Pascual-Teresa, B., Ramos, A. & Herradón, G., 15 Jul 2018, In: Neuropharmacology. 137, p. 86-95 10 p.

    Research output: Contribution to journalArticlepeer-review

  7. Chronic amphetamine enhances visual input to and suppresses visual output from the superior colliculus in withdrawal

    Turner, A., Kraev, I., Stewart, M. G., Stramek, A., Overton, P. G. & Dommett, E. J., 4 Jun 2018, In: Neuropharmacology.

    Research output: Contribution to journalArticlepeer-review

  8. Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system

    Di Menna, L., Joffe, M. E., Iacovelli, L., Orlando, R., Lindsley, C. W., Mairesse, J., Gressèns, P., Cannella, M., Caraci, F., Copani, A., Bruno, V., Battaglia, G., Conn, P. J. & Nicoletti, F., Jan 2018, In: Neuropharmacology. 128, p. 301-313 13 p.

    Research output: Contribution to journalArticlepeer-review

  9. Psychiatry & the psychedelic drugs. Past, present & future

    Rucker, J. J. H., Iliff, J. & Nutt, D. J., 25 Dec 2017, In: Neuropharmacology.

    Research output: Contribution to journalArticlepeer-review

  10. Astrocytes modulate thalamic sensory processing via mGlu2 receptor activation

    Copeland, C. S., Wall, T. M., Sims, R. E., Neale, S. A., Nisenbaum, E., Parri, H. R. & Salt, T. E., 15 Jul 2017, In: Neuropharmacology. 121, p. 100-110 11 p.

    Research output: Contribution to journalArticlepeer-review

  11. Cannabis-associated psychosis: Neural substrate and clinical impact

    Murray, R. M., Englund, A., Abi-Dargham, A., Lewis, D. A., Di Forti, M., Davies, C., Sherif, M., McGuire, P. & D'Souza, D. C., 17 Jun 2017, In: Neuropharmacology. 124, p. 89-104 16 p.

    Research output: Contribution to journalReview articlepeer-review

  12. The binding orientations of structurally-related ligands can differ; A cautionary note

    Ruepp, M-D., Wei, H., Leuenberger, M., Lochner, M. & Thompson, A. J., Jun 2017, In: Neuropharmacology. 119, p. 48-61 14 p.

    Research output: Contribution to journalArticlepeer-review

  13. GABAB receptors and pain

    Malcangio, M., 11 May 2017, In: Neuropharmacology.

    Research output: Contribution to journalArticlepeer-review

  14. The binding orientation of epibatidine at α7 nACh receptors

    Thompson, A. J., Metzger, S., Lochner, M. & Ruepp, M. D., 1 Apr 2017, In: Neuropharmacology. 116, p. 421-428 8 p.

    Research output: Contribution to journalArticlepeer-review

  15. (I) Pharmacological profiling of a novel modulator of the α7 nicotinic receptor: Blockade of a toxic acetylcholinesterase-derived peptide increased in Alzheimer brains

    Garcia-Ratés, S., Morrill, P., Tu, H., Pottiez, G., Badin, A-S., Tormo-Garcia, C., Heffner, C., Coen, C. W. & Greenfield, S. A., Jun 2016, In: Neuropharmacology. 105, p. 487-499 13 p.

    Research output: Contribution to journalArticlepeer-review

  16. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals

    Vidal, B., Sebti, J., Verdurand, M., Fieux, S., Billard, T., Streichenberger, N., Troakes, C., Newman-Tancredi, A. & Zimmer, L., 13 May 2016, In: Neuropharmacology.

    Research output: Contribution to journalArticlepeer-review

  17. A fluorescent approach for identifying P2X1 ligands

    Ruepp, M-D., Brozik, J. A., de Esch, I. J., Farndale, R. W., Murrell-Lagnado, R. D. & Thompson, A. J., 1 Nov 2015, In: Neuropharmacology. 98, Special Issue entitled ‘Fluorescent Tools in Neuropharmacology’, p. 13-21 9 p.

    Research output: Contribution to journalArticlepeer-review

  18. Tracking individual membrane proteins and their biochemistry: The power of direct observation

    Barden, A. O., Goler, A. S., Humphreys, S. C., Tabatabaei, S., Lochner, M., Ruepp, M. D., Jack, T., Simonin, J., Thompson, A. J., Jones, J. P. & Brozik, J. A., 1 Nov 2015, In: Neuropharmacology. 98, p. 22-30 9 p.

    Research output: Contribution to journalReview articlepeer-review

  19. Characterizing new fluorescent tools for studying 5-HT3 receptor pharmacology

    Jack, T., Simonin, J., Ruepp, M. D., Thompson, A. J., Gertsch, J. & Lochner, M., 1 Mar 2015, In: Neuropharmacology. 90, p. 63-73 11 p.

    Research output: Contribution to journalArticlepeer-review

  20. A role for hippocampal PSA-NCAM and NMDA-NR2B receptor function in flavonoid-induced spatial memory improvements in young rats

    Rendeiro, C., Foley, A., Lau, V. C., Ring, R., Rodriguez-Mateos, A., Vauzour, D., Williams, C. M., Regan, C. & Spencer, J. P. E., Apr 2014, In: Neuropharmacology. 79, p. 335-44 10 p.

    Research output: Contribution to journalArticlepeer-review

  21. The actions of Pasteurella multocida toxin on neuronal cells

    Surguy, S., Duricki, D., Reilly, J., Lax, A. & Robbins, J., Feb 2014, In: Neuropharmacology. 77, N/A, p. 9-18 10 p.

    Research output: Contribution to journalArticlepeer-review

  22. A role for tau at the synapse in Alzheimer's disease pathogenesis

    Pooler, A. M., Noble, W. & Hanger, D. P., 1 Jan 2014, In: Neuropharmacology. 76 , Pt A, p. 1-8 8 p., N/A.

    Research output: Contribution to journalArticlepeer-review

  23. Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord

    Bannister, K., Lee, Y. S., Goncalves, L., Porreca, F., Lai, J. & Dickenson, A. H., 2014, In: Neuropharmacology. 85, p. 375-383 9 p.

    Research output: Contribution to journalArticlepeer-review

  24. The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: A pilot [11C]Ro15-4513 positron emission tomography study

    Mendez, M. A., Horder, J., Myers, J., Coghlan, S., Stokes, P., Erritzoe, D., Howes, O., Lingford-Hughes, A., Murphy, D. & Nutt, D., 1 May 2013, In: Neuropharmacology. 68, p. 195-201 7 p.

    Research output: Contribution to journalArticlepeer-review

  25. Novel multitarget ligand ITH33/IQM9.21 provides neuroprotection in in vitro and in vivo models related to brain ischemia

    Lorrio, S., Gómez-Rangel, V., Negredo, P., Egea, J., Leon, R., Romero, A., Dal-Cim, T., Villarroya, M., Rodriguez-Franco, M. I., Conde, S., Arce, M. P., Roda, J. M., García, A. G. & López, M. G., Apr 2013, In: Neuropharmacology. 67, N/A, p. 403-411 9 p., N/A.

    Research output: Contribution to journalArticlepeer-review

  26. What should we do about student use of cognitive enhancers? An analysis of current evidence

    Ragan, C. I., Bard, I., Singh, I. & Independent Scientific Committee on Drugs, Jan 2013, In: Neuropharmacology. 64, p. 588-595 8 p.

    Research output: Contribution to journalArticlepeer-review

  27. Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease

    Kovacs, A. D., Saje, A., Wong, A., Ramji, S., Cooper, J. D. & Pearce, D. A., Oct 2012, In: Neuropharmacology. 63, 5, p. 769-775 7 p.

    Research output: Contribution to journalArticlepeer-review

  28. The role of the gut/brain axis in modulating food intake

    Sam, A. H., Troke, R. C., Tan, T. M. & Bewick, G., Jul 2012, In: Neuropharmacology. 63, 1, p. 46-56 11 p., N/A.

    Research output: Contribution to journalLiterature reviewpeer-review

  29. Memantine potentiates hippocampal theta oscillations at a therapeutic dose in anesthetized mice: A mechanistic link to its cognitive-enhancing properties

    Guadagna, S., Bundgaard, C., Hovelso, N., Volbracht, C., Francis, P. T., Egebjerg, J. & Sotty, F., Jun 2012, In: Neuropharmacology. 62, 7, p. 2208-2218 11 p.

    Research output: Contribution to journalArticlepeer-review

  30. Potentiation of sensory responses in ventrobasal thalamus in vivo via selective modulation of mGlu1 receptors with a positive allosteric modulator

    Salt, T. E., Jones, H. E., Andolina, I. M., Copeland, C. S., Clements, J. T. C., Knoflach, F. & Sillito, A. M., Mar 2012, In: Neuropharmacology. 62, 4, p. 1695-9 5 p.

    Research output: Contribution to journalArticlepeer-review

  31. αCaMKII autophosphorylation controls exploratory activity to threatening novel stimuli

    Easton, A. C., Lucchesi, W., Schumann, G., Giese, K. P., Mueller, C. P. & Fernandes, C., Dec 2011, In: Neuropharmacology. 61, 8, p. 1424-1431 8 p.

    Research output: Contribution to journalArticlepeer-review

  32. Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum

    Egeland, M., Warner-Schmidt, J., Greengard, P. & Svenningsson, P., Sep 2011, In: Neuropharmacology. 61, 3, p. 442-450 9 p.

    Research output: Contribution to journalArticlepeer-review

  33. Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease

    Kovacs, A. D., Saje, A., Wong, A., Szenasi, G., Kiricsi, P., Szabo, E., Cooper, J. D. & Pearce, D. A., Feb 2011, In: Neuropharmacology. 60, 2-3, p. 405 - 409 5 p.

    Research output: Contribution to journalArticlepeer-review

  34. Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects

    Buckley, C., Marguerie, A., Roach, A., Goldsmith, P., Fleming, A., Alderton, W. & Franklin, R., Sep 2010, In: Neuropharmacology. 59, 3, p. 149-59 11 p., 20450924.

    Research output: Contribution to journalArticlepeer-review

  35. Neurochemical basis for symptomatic treatment of Alzheimer's disease

    Francis, P. T., Ramirez, M. J. & Lai, M. K., Sep 2010, In: Neuropharmacology. 59, 4-5, p. 221 - 229 9 p.

    Research output: Contribution to journalLiterature reviewpeer-review

  36. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis

    Destot-Wong, K-D., Liang, K., Gupta, S. K., Favrais, G., Schwendimann, L., Pansiot, J., Baud, O., Spedding, M., Lelièvre, V., Mani, S. & Gressens, P., Sep 2009, In: Neuropharmacology. 57, 3, p. 277-286 10 p., N/A.

    Research output: Contribution to journalArticlepeer-review

  37. Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin

    Vellani, V., Petrosino, S., De Petrocellis, L., Valenti, M., Prandini, M., Magherini, P. C., McNaughton, P. & Di Marzo, V., Dec 2008, In: Neuropharmacology. 55, 8, p. 1274-1279 6 p.

    Research output: Contribution to journalArticlepeer-review

  38. The group III mGlu receptor agonist L-AP4 affords both neurochemical and functional neuroprotection against a 6-hydroxydopamine lesion of the substantia nigra in rats

    Betts, M. T. J., O'Neill, M. J., Mitchell, S. N. & Duty, S., 2008, In: Neuropharmacology. 55, 4, p. 587 - 587 1 p.

    Research output: Contribution to journalMeeting abstract

  39. Differential regulation of microglial P2X4 and P2X7 ATP receptors following LPS-induced activation

    Raouf, R., Chabot-Doré, A-J., Ase, A. R., Blais, D. & Séguéla, P., Sep 2007, In: Neuropharmacology. 53, 4, p. 496-504 9 p.

    Research output: Contribution to journalArticlepeer-review

  40. Double dissociating effects of sensory stimulation and cocaine on serotonin activity in the occipital and temporal cortices

    Müller, C. P., De Souza Silva, M. A. & Huston, J. P., Mar 2007, In: Neuropharmacology. 52, 3, p. 854 - 862 9 p.

    Research output: Contribution to journalArticlepeer-review

  41. The indirect serotonergic agonist D-fenfluramine and prepulse inhibition in healthy men

    Abel, K. M., Allin, M., Van Amelsvoort, T., Hemsley, D. & Geyer, M. A., Mar 2007, In: Neuropharmacology. 52, 4, p. 1088 - 1094 7 p.

    Research output: Contribution to journalArticlepeer-review

  42. Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and a6 and b3 nicotine acetylcholine receptor subumit mRNA in the substantia nigra pars compacta of the rat

    Visanji, N. P., Mitchell, S. N., O'Neill, M. J. & Duty, S., Jan 2006, In: Neuropharmacology. 50, 1, p. 36 - 46 11 p.

    Research output: Contribution to journalArticlepeer-review

  43. Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI

    Koning (nee Dixon), A., Prior, M., Morris, P. M., Shah, Y. B., Joseph, M. H. & Young, A. M. J., Feb 2005, In: Neuropharmacology. 48, 2, p. 236-245 10 p.

    Research output: Contribution to journalArticlepeer-review

  44. Activation of Group II and Group III metabotropic glutamate receptors by endogenous ligand(s) and the modulation of synaptic transmission in the superficial superior colliculus

    Thompson, H., Neale, S. & Salt, T., Nov 2004, In: Neuropharmacology. 47, 6, p. 822-832 11 p.

    Research output: Contribution to journalArticlepeer-review

  45. Nucleus accumbens serotonin1A receptors control cocaine-induced hyperactivity but not local serotonin increase: an in vivo microdialysis study

    Müller, C. P., Thönnessen, H., De Souza Silva, M. A., Fink, H., Bert, B., Carey, R. J. & Huston, J. P., Aug 2004, In: Neuropharmacology. 47, 2, p. 205 - 215 11 p.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 Next

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454